Please provide your email address to receive an email when new articles are posted on . The FDA has approved durvalumab plus fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy as ...

Previously, it was only available on PC handhelds. Previously, it was only available on PC handhelds. is a senior reporter covering technology, gaming, and more. He joined The Verge in 2019 after ...

Forbes contributors publish independent expert analyses and insights. Shep Hyken is a customer service/CX expert, author & keynote speaker. Steve Spangler is a teacher, businessman and Emmy ...

It’s one of humanity’s most enduring mysteries: What happens when we die? Now, a new scientific investigation has taken us a step closer to understanding what may lie beyond the grave, the Daily Mail ...

They were at death’s door and opened a window to a whole new world. About 15% of severely ill patients report enduring a near-death experience (NDE), which may mean having an overwhelming out-of-body ...

Samsung has announced an expansion of its Samsung Experience Stores retail outlets, opening by the end of November in California (Los Cerritos Center), New York (Queens Center), and Minnesota (Mall of ...

Chemotherapy-induced cognitive impairment, also called “chemobrain”, has been heavily researched as a major side effect of cancer treatment. Although breast cancer has a 91% survival rate in the ...

A letter of experience is a document you get from an old insurance company to give to a new one. It gives other companies information about your coverage and claims history. These letters inform other ...

Chicago! “Drag Race” is ready to serve you with a brand new immersive experience. “Drag Race: The Experience” will celebrate charisma, uniqueness, nerve and talent, taking fans beyond the screen and ...

This is an edition of The Wonder Reader, a newsletter in which our editors recommend a set of stories to spark your curiosity and fill you with delight. Sign up here to get it every Saturday morning. ...

5-Fluorouracil 4% cream achieved total clearance in 54.5% and partial clearance in 24.2% of hyperkeratotic actinic keratosis (AK) lesions at 3 months, demonstrating a good safety profile with high ...